American Century Companies Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

American Century Companies Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $14 Million - $14.7 Million	96,781 Added 50.66%	287,812 $43.5 Million
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $41.1 Million - $72.1 Million	-493,803 Reduced 72.11%	191,031 $27.8 Million
Q1 2022 May 11, 2022	BUY	$110.08 - $142.92 $54.4 Million - $70.6 Million	494,275 Added 259.38%	684,834 $81.2 Million
Q4 2021 Feb 07, 2022	SELL	$99.73 - $148.48 $8.8 Million - $13.1 Million	-88,217 Reduced 31.64%	190,559 $26.3 Million
Q3 2021 Nov 10, 2021	BUY	$98.85 - $138.91 $9 Million - $12.6 Million	91,051 Added 48.5%	278,776 $38.7 Million
Q2 2021 Aug 05, 2021	BUY	$65.78 - $105.02 $111,562 - $178,113	1,696 Added 0.91%	187,725 $18.2 Million
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $168,440 - $241,210	-2,629 Reduced 1.39%	186,029 $12.7 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $689,156 - $1.04 Million	10,591 Added 5.95%	188,658 $16.2 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $1.64 Million - $2.17 Million	27,811 Added 18.51%	178,067 $11.6 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $2.16 Million - $5.53 Million	74,466 Added 98.25%	150,256 $11 Million
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $2.08 Million - $4.34 Million	75,790 New	75,790 $2.58 Million
Q1 2018 May 03, 2018	SELL	$22.49 - $34.56 $1.29 Million - $1.98 Million	-57,216 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$20.44 - $35.56 $417,875 - $726,988	20,444 Added 55.6%	57,216 $1.54 Million
Q3 2017 Nov 01, 2017	BUY	$23.54 - $38.21 $865,612 - $1.41 Million	36,772	36,772 $1.38 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.